Skip to content
OpenCapital
Get started

Iovance Biotherapeutics, Inc. IOVA Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Nuvation Bio logo
Nuvation BioNUVB
$1.49B+150%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$5.06B+74.2%

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Enterprise value$1.83B+33.2%
P/S6.9×-0.1×

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Computed from the period-end share price: $1.45B.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s market capitalization?
Iovance Biotherapeutics, Inc. (IOVA) reported market capitalization of $1.45B in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s market capitalization changed year-over-year?
Iovance Biotherapeutics, Inc.'s market capitalization increased by 32.4% year-over-year, from $1.09B to $1.45B.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s market capitalization has grown at a -30.8% compound annual growth rate (CAGR), from $6.84B to $1.08B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.